Category Archives: Globe Newswire

K2 Therapeutics Recognized as a 2026 Endpoints 11 Honoree

BOSTON and SINGAPORE, Sept. 25, 2026 (GLOBE NEWSWIRE) — K2 Therapeutics (K2), a biotechnology company built for global impact, today announced that it has been named by Endpoints News as one of the 2026 Endpoints 11. Published annually, the Endpoints 11 recognizes the most promising private biotech companies in the world, celebrating innovators who are challenging […]

Hypersonic Flight Market to Reach USD 1,154 Million by 2030, Growing at 5.7% CAGR, Says MarketsandMarkets™

Delray Beach, FL, Sept. 25, 2026 (GLOBE NEWSWIRE) — The global Hypersonic Flight Market was estimated to be worth USD 782 million in 2023 and is projected to reach USD 1,154 million by 2030, growing at a CAGR of 5.7% during the forecast period, according to a report by MarketsandMarkets™. Growth is being driven by […]

Concrete Superplasticizers Market to Reach USD 10.54 Billion by 2031, at a CAGR of 5.8% — MarketsandMarkets™

Delray Beach, FL, Sept. 25, 2026 (GLOBE NEWSWIRE) — The global Concrete Superplasticizers Market is projected to grow from USD 7.93 billion in 2026 to USD 10.54 billion by 2031, registering a CAGR of 5.8% during 2026–2031. Concrete superplasticizers are high-performance chemical admixtures that improve concrete workability, flow, and strength while reducing the water content […]

Star Fashion Culture Holdings Limited Announces Pricing of Approximately US$9,600,000 Million Public Offering of Class A Ordinary Shares

XIAMEN, Sept. 25, 2026 (GLOBE NEWSWIRE) — STAR FASHION CULTURE HOLDINGS LIMITED (NASDAQ: STFS) (the “Company” or “STFS”) today announced the pricing of its best-efforts follow-on public offering on September 25, 2026 of 12,000,000 Class A ordinary shares at a public offering price of $0.80 per Class A ordinary share (the “Offering”). Kingswood Capital Partners, […]

Fangzhou Releases 2026 Interim Report, Deepening “AI + Chronic Care” as a Lifetime Health Service Partner

SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report, highlighting continued progress in its “AI + Chronic Disease Services” strategy as the Company advances its positioning as a full-lifecycle personal health service partner. In […]

41Caijing Co-Hosts Hangzhou Forum on New Growth Opportunities for Chinese Brands Expanding Overseas

41Caijing Co-Hosts Hangzhou Forum on New Growth Opportunities for Chinese Brands Expanding Overseas

Zhou Xuechun, Head of East China Business at 41Caijing, Shares Insights on Marketing Opportunities and Communications Strategies for Chinese Brands Going Global Hangzhou, China, Sept. 25, 2026 (GLOBE NEWSWIRE) — On September 16, 2026, the “Industrial Clusters Going Global: New Growth for Chinese Brands” forum was held at Hangzhou International Expo Center. Hosted by Hugo […]

Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks

LONDON, Sept. 25, 2026 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), a leading provider of Sustainability RegTech solutions, today announced that its Board of Directors has resolved to convene an Extraordinary General Meeting of shareholders (the “EGM”) to be held on Thursday, October 8, 2026 at 10:00 a.m. (Eastern Time), virtually […]

Arbe Robotics Ltd. Announces $15 Million Underwritten Registered Direct Offering

TEL AVIV, ISRAEL, Sept. 25, 2026 (GLOBE NEWSWIRE) — Arbe Robotics Ltd. (NASDAQ: ARBE), (TASE: ARBE) (“Arbe” or the “Company”), a global leader in ultra-high-resolution radar solutions, today announced that it has priced an underwritten registered direct offering of 833,334 ordinary shares at a purchase price of $0.60 per share and, in lieu of ordinary […]

Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% – SNS Insider

Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% - SNS Insider

U.S. Enzyme Replacement Therapy Market to reach USD 9.30 billion and Europe Market to reach USD 8.08 billion by 2035 as newborn screening, orphan drug incentives, and rare disease diagnosis fuel demand. Austin, Texas, Sept. 25, 2026 (GLOBE NEWSWIRE) — Enzyme Replacement Therapy Market Size & Growth Analysis: According to SNS Insider, The Enzyme Replacement […]

Automated Test Equipment Market to Worth $13.87 Billion by 2035 | at CAGR 5.13% | SNS Insider

Automated Test Equipment Market to Worth $13.87 Billion by 2035 | at CAGR 5.13% | SNS Insider

U.S. Automated Test Equipment Market was Estimated at USD 1.57 Billion in 2025 and Expected to Reach USD 2.56 Billion by 2035 Similarly, Europe is projected to reach USD 2.66 Billion by 2035 Austin, Sept. 25, 2026 (GLOBE NEWSWIRE) — As per SNS Insider, The Automated Test Equipment Market was valued at USD 8.41 Billion […]